drugset / Trial / NCT01641796

Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis

NCT01641796

Expanded access No longer available U.S. Army Medical Research and Development Command

Summary

This is an expanded access treatment protocol designed to provide a topical cream treatment option to military health care beneficiaries with parasitologically confirmed uncomplicated Cutaneous Leishmaniasis.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paromomycin Small molecule Topical